Clinical Trial: Omega-3, Autism Spectrum Disorder (ASD)

U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07365553) titled 'Omega-3, Autism Spectrum Disorder (ASD)' on May 22, 2024.

Brief Summary: This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).

Study Start Date: July 15, 2022

Study Type: INTERVENTIONAL

Condition: ASD

Intervention: DIETARY_SUPPLEMENT: Omega-3

Omega-3 PUFAs

DIETARY_SUPPLEMENT: Placebo

Soybean Oil

Recruitment Status: RECRUITING

Sponsor: China Medical University Hospital

Information provided by (Responsible Party): Pei-Chen Chang, China Medical University Hospital

Published by HT Digital Content Services with permission from Health Da...